The Global Biochips Market was worth $7.15 billion in 2016 and estimated to be growing at a CAGR of 21.80%, to reach $19.17 billion by 2021. A biochip is a assembly of miniaturized test sites that are organized on a compact substrate, which allows many tests to be executed at the same time to reach higher throughput and speed.
